Clinical Trial

Optimization of Commissural Alignment During Transcatheter Aortic Valve Implantation With Evolut FX+

Study acronym: ALIGN-EFX
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 16, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Purpose of the Study The purpose of this study is to investigate how a transcatheter aortic valve (TAVI, biological valve prosthesis) can best be positioned in order to avoid blockage of the coronary arteries by the valve material after implantation. Method The study will include patients undergoing TAVI. Participants will be randomized, meaning that it will be determined by chance which of two established implantation techniques is used. Both techniques are already part of routine clinical practice. Examinations After the procedure, a CT scan will be performed to evaluate the position of the valve in relation to the coronary arteries. This CT scan is the only additional examination beyond today's standard clinical practice. Significance If one of the techniques proves to provide better positioning of the valve, this method may be recommended as standard practice in future treatment. The study will therefore contribute to improved patient safety and treatment quality, as well as increase knowledge about optimal positioning and implantation techniques in TAVI.
Trial Details
NCT Number NCT07217691
Lead Sponsor Oslo University Hospital
Conditions Aortic Stenosis, Trans-catheter Aortic Valve Implantation, Commissural Alignment
Enrollment 40 participants
Start Date 2025-11-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-16